Cargando…

The Effect of Pioglitazone and Metformin on Liver Function Tests, Insulin Resistance, and Liver Fat Content in Nonalcoholic Fatty Liver Disease: A Randomized Double Blinded Clinical Trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is considered as the hepatic manifestation of insulin resistance (IR) syndrome. The effect of insulin sensitizers on liver function tests and metabolic indices in NAFLD patients is a matter of debate. OBJECTIVES: The aim of study was to compare t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Razavizade, Mohsen, Jamali, Raika, Arj, Abbas, Matini, Seyyed Mohammad, Moraveji, Alireza, Taherkhani, Effat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736624/ https://www.ncbi.nlm.nih.gov/pubmed/23930133 http://dx.doi.org/10.5812/hepatmon.9270

Ejemplares similares

Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines
por: Jamali, Raika, et al.
Publicado: (2016)

The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Subjects With Non-Alcoholic Fatty Liver Disease: A Randomized Open-Label Clinical Trial
por: Jamali, Raika, et al.
Publicado: (2013)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
por: Liu, Jieying, et al.
Publicado: (2023)

Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients
por: Jamali, Raika, et al.
Publicado: (2020)

The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease
por: Jamali, Raika, et al.
Publicado: (2016)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Effect of Pioglitazone on Nonalcoholic Fatty Liver Disease in Morbid Obese Patients; a Randomized Controlled Trial
por: Sayadishahraki, Masoud, et al.
Publicado: (2023)

Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease
por: Lv, Shujing, et al.
Publicado: (2018)

Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
por: Ahn, Hwa Young, et al.
Publicado: (2018)

Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
por: Vittal, Anusha, et al.
Publicado: (2020)

Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
por: Shrestha, Rupesh, et al.
Publicado: (2021)

Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
por: Yan, Hongmei, et al.
Publicado: (2021)

Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
por: Jianfang, Fu, et al.
Publicado: (2023)

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
por: Dongiovanni, P., et al.
Publicado: (2017)

The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
por: Ohki, Takamasa, et al.
Publicado: (2012)

Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease
por: Shamsoddini, Alireza, et al.
Publicado: (2015)

Comments on “The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease”
por: Cheraghpour, Makan, et al.
Publicado: (2016)

Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology
por: Huang, Yuanshe, et al.
Publicado: (2022)

Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Jung, Chan-Hee, et al.
Publicado: (2020)

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
por: Zeybel, Mujdat, et al.
Publicado: (2021)

Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study
por: Jamali, Raika, et al.
Publicado: (2015)

The Correlation between Serum Zinc Level and Liver Histology in Non-Alcoholic Steatohepatitis
por: Kosari, Farid, et al.
Publicado: (2019)

Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2, and oipA genotypes in patients with upper gastrointestinal diseases
por: Sedaghat, Hossein, et al.
Publicado: (2014)

The Eeffect of Metformin Combined with Calcium-Vitamin D(3) Against Diet-Induced Nonalcoholic Fatty Liver Disease
por: Shojaei Zarghani, Sara, et al.
Publicado: (2018)

Impact of standard treatment on the quality of life of non-alcoholic fatty liver disease patients
por: Jamali, Raika, et al.
Publicado: (2021)

Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study
por: Hajiaghamohammadi, Ali Akbar, et al.
Publicado: (2012)

Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies
por: Reinshagen, Mona, et al.
Publicado: (2023)

Noninvasive Quantification of Liver Fat Content by Different Gradient Echo Magnetic Resonance Imaging Sequences in Patients with Nonalcoholic Fatty Liver Disease
por: Zabihzadeh, Mansour, et al.
Publicado: (2018)

The association of pericardial fat and peri-aortic fat with severity of nonalcoholic fatty liver disease
por: Lee, Chun-Wei, et al.
Publicado: (2022)

Impact of Visceral Fat on the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
por: Jeong, Seul-Ki, et al.
Publicado: (2008)

The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial
por: Jamali, Arsia, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease stratification by liver lipidomics
por: Vvedenskaya, Olga, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction
por: Ye, Junzhao, et al.
Publicado: (2019)

Long-Term Effects of Metformin and Lifestyle Modification on Nonalcoholic Fatty Liver Disease Obese Adolescents
por: Tock, Lian, et al.
Publicado: (2010)

A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice
por: Bruckbauer, Antje, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_53p2jfgq1tigql58hhlu7kmuo7